948349-66-4

Usage

Uses

Used in Organic Synthesis:
4-bromo-3-ethoxymethyl-benzoic acid ethyl ester is used as an intermediate in organic synthesis for the preparation of more complex organic molecules. Its unique functional groups, including the bromine atom, ethoxy group, and ethyl ester, make it a versatile building block for creating a variety of compounds.
Used in Chemical Research:
4-bromo-3-ethoxymethyl-benzoic acid ethyl ester is used in chemical research to study its properties and potential applications. Its unique structure and functional groups make it an interesting compound for researchers to explore its reactivity, stability, and potential uses in various chemical reactions and processes.
Used in Pharmaceutical Industry:
4-bromo-3-ethoxymethyl-benzoic acid ethyl ester may be used as a building block or intermediate in the synthesis of pharmaceutical compounds. Its unique structure and functional groups can be utilized to create new drugs or improve the properties of existing ones.
Used in Agrochemical Industry:
4-bromo-3-ethoxymethyl-benzoic acid ethyl ester may also be used in the agrochemical industry for the development of new pesticides, herbicides, or other agricultural chemicals. Its unique structure and functional groups can be leveraged to create more effective and environmentally friendly products.

Upstream product

• 160313-69-9 ethyl 3-methyl-4-bromobenzoate 
• 347852-72-6 ethyl 4-bromo-3-(bromomethyl)benzoate 
• 141-52-6 sodium ethanolate 

Downstream Products

• 254740-64-2 4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl) [1,1'-biphenyl]-2-sulfonamide 
• 1255948-71-0 1-bromo-2-ethoxymethyl-4-hydroxymethylbenzene 
• 948349-70-0 4-{2-[(4,5-dimethyl-isoxazol-3-yl)-(2-methoxy-ethoxymethyl)-sulphamoyl]-5-methyl-thiophene-3-yl}-3-ethoxymethyl-benzoic acid ethyl ester 

Relevant academic research and scientific papers

Dual antagonist of angiotensin II receptor and endothelin receptor

The invention relates to dual antagonists of an angiotensin II receptor and an endothelin receptor. Specifically, the invention provides a compound represented by a formula I and a preparation method thereof. The compound can be used for treating diseases

A BIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR ANTAGONIST TO TREAT GLOMERULOSCLEROSIS

Methods of administering and pharmaceutical compositions of a biphenyl sulphonamide compound which is a dual angiotensin and endothelin receptor antagonist are disclosed for treating diseases.

NOVEL DUAL ACTION RECEPTORS ANTAGONISTS (DARA) AT THE AT1 AND ETA RECEPTORS

The present invention relates to new compounds of the formula [Chemical formula should be inserted here. Please see paper copy] wherein R1, R2, R3, and R31 are as specified herein. The invention also relates to a method for preparation thereof, as well as combinations of the new compounds with previously known agents. The invention also relates to the use of the above-mentioned compounds and combinations for the preparation of a medicament for treating hypertension of different kinds, alleviating organ damage of different kinds, treating or preventing diabetic nephropathy, treating endothelin and angiotensin mediated disorders, and treating prostate cancer.

Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists

Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutica

Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists

Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutica